Adult and juvenile dermatomyositis treatment.
Patil A, Lu J, Kassir M, Babaei M, Goldust M.
J Cosmet Dermatol. 2023 Feb;22(2):395-401. doi: 10.1111/jocd.15363. Epub 2022 Sep 16.
[Dermatomyositis: new antibody, new classification].
Bolko L, Gitiaux C, Allenbach Y.
Med Sci (Paris). 2019 Nov;35 Hors série n° 2:18-23. doi: 10.1051/medsci/2019178. Epub 2019 Dec 20.
Juvenile dermatomyositis. Where are we now?
McCann LJ, Livermore P, Wilkinson MGL, Wedderburn LR.
Clin Exp Rheumatol. 2022 Feb;40(2):394-403. doi: 10.55563/clinexprheumatol/56ilob. Epub 2022 Feb 7.
Recent Advances in Pharmacological Treatments of Adult Dermatomyositis.
Chen KL, Zeidi M, Werth VP.
Curr Rheumatol Rep. 2019 Aug 31;21(10):53. doi: 10.1007/s11926-019-0850-9.
Polymyositis and dermatomyositis (first of two parts).
Bohan A, Peter JB.
N Engl J Med. 1975 Feb 13;292(7):344-7. doi: 10.1056/NEJM197502132920706.
Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome.
Cassius C, Le Buanec H, Bouaziz JD, Amode R.
J Immunol Res. 2019 Jan 14;2019:9141420. doi: 10.1155/2019/9141420. eCollection 2019.
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects.
Rider LG, Ruperto N, Pistorio A, Erman B, Bayat N, Lachenbruch PA, Rockette H, Feldman BM, Huber AM, Hansen P, Oddis CV, Lundberg IE, Amato AA, Chinoy H, Cooper RG, Chung L, Danko K, Fiorentino D, García-De la Torre I, Reed AM, Wook Song Y, Cimaz R, Cuttica RJ, Pilkington CA, Martini A, van der Net J, Maillard S, Miller FW, Vencovsky J, Aggarwal R; International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation.
Rheumatology (Oxford). 2017 Nov 1;56(11):1884-1893. doi: 10.1093/rheumatology/kex226.
JAK inhibitors for the treatment of adult dermatomyositis: A pilot study.
Landon-Cardinal O, Guillaume-Jugnot P, Toquet S, Sbeih N, Rigolet A, Champtiaux N, Dorgham K, Gorochov G, Meyer A, Anquetil C, Barete S, Benveniste O, Allenbach Y.
J Am Acad Dermatol. 2023 Apr;88(4):924-926. doi: 10.1016/j.jaad.2022.10.055. Epub 2022 Nov 8.
Macrophage activation syndrome in adult dermatomyositis: a case-based review.
Kishida D, Sakaguchi N, Ueno KI, Ushiyama S, Ichikawa T, Yoshinaga T, Shimojima Y, Sekijima Y.
Rheumatol Int. 2020 Jul;40(7):1151-1162. doi: 10.1007/s00296-020-04590-9. Epub 2020 Apr 30.
Juvenile dermatomyositis.
Quartier P, Gherardi RK.
Handb Clin Neurol. 2013;113:1457-63. doi: 10.1016/B978-0-444-59565-2.00014-9.
